GTx Up Nearly 26% (GTXI)

Shares of GTx, Inc. (NASDAQ: GTXI) are soaring this morning after the tiny biotech company was upgraded at Citigroup.

At last check, shares of GTx, Inc. were up 73 cents to $3.48, a gain of 26.5%.

GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules to treat cancer, osteoporosis and bone loss, muscle loss, and other serious medical conditions.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.